Assembly Biosciences, Inc. (ASMB) vs Capricor Therapeutics, Inc. (CAPR)
- Assembly Biosciences, Inc. ASMB 20.65 −9.31%
- Capricor Therapeutics, Inc. CAPR 6.95 −6.96%
Assembly Biosciences, Inc. and Capricor Therapeutics, Inc. are both Biotechnology companies. Assembly Biosciences, Inc. and Capricor Therapeutics, Inc. are of similar size ($479.1M and $455.2M). Capricor Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Assembly Biosciences, Inc. trades at 22.3×. Assembly Biosciences, Inc. grew revenue faster over the last twelve months: 125.1% against −11.6%. Capricor Therapeutics, Inc. has the higher net margin (0.00% vs −0.06%) and the lower return on invested capital (−1,019.7% vs 0.00%). Across the 16 metrics below, Assembly Biosciences, Inc. leads on 10 and Capricor Therapeutics, Inc. on 6.
Valuation
Profitability
| Metric | ASMB | CAPR | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | (11.75%) | 0.00% | 0.00% |
| Net margin | (0.06%) | 0.00% | 0.00% |
| Free cash flow margin | (51.53%) | 0.00% | 0.00% |
| Return on equity | (0.03%) | (73.70%) | (56.66%) |
| Return on assets | (0.02%) | (51.53%) | (49.22%) |
| Return on invested capital | 0.00% | (1,019.73%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack